Cargando…

The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects

Background: Flurbiprofen axetil is a prodrug that releases the active substance through enzymatic removal of the ester moiety. It is formulated through encapsulation in a lipid microsphere carrier, and widely used to treat perioperative pain. Here, we studied the distribution of R (−)- and S (+)-flu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Han, Luo, Xingxian, Zhang, Hong, An, Haiyan, Feng, Wanyu, Feng, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120306/
https://www.ncbi.nlm.nih.gov/pubmed/33995057
http://dx.doi.org/10.3389/fphar.2021.646196
_version_ 1783692038496059392
author Yao, Han
Luo, Xingxian
Zhang, Hong
An, Haiyan
Feng, Wanyu
Feng, Yi
author_facet Yao, Han
Luo, Xingxian
Zhang, Hong
An, Haiyan
Feng, Wanyu
Feng, Yi
author_sort Yao, Han
collection PubMed
description Background: Flurbiprofen axetil is a prodrug that releases the active substance through enzymatic removal of the ester moiety. It is formulated through encapsulation in a lipid microsphere carrier, and widely used to treat perioperative pain. Here, we studied the distribution of R (−)- and S (+)-flurbiprofen in human plasma and cerebrospinal fluid (CSF) after intravenous injection of flurbiprofen axetil. Methods: A total of 70 adult patients undergoing elective lower limb surgery under spinal anesthesia were given a single intravenous injection of 100-mg flurbiprofen axetil. The patients were randomly assigned to 10 groups for plasma and CSF sampling at 10 time points (5–50 min) after subarachnoid puncture and before actual spinal anesthesia. R (−)- and S (+)-flurbiprofen and CSF/plasma ratio were determined by liquid chromatography–tandem mass spectrometry. Results: R (−)-flurbiprofen concentration ranged from 2.01 to 10.9 μg/mL in plasma and 1.46–34.4 ng/mL in CSF. S (+)-flurbiprofen concentration ranged from 1.18 to 10.8 μg/mL in plasma and from 2.53 to 47 ng/mL in CSF. In comparison to S (+)-flurbiprofen, R (−)-flurbiprofen concentration was significantly higher in plasma at all time points (p < 0.05) except at 30 or 40 min, and lower in CSF at all time points (p < 0.05) except at 10, 15 and 40 min. Analysis after correcting drug concentration for body mass index also revealed higher plasma and lower CSF R (−)-flurbiprofen concentration. In comparison to S (+)-flurbiprofen, AUC(0–50) for R (−)-flurbiprofen was larger in plasma and smaller in CSF (p < 0.05 for both), and accordingly smaller CSF/plasma AUC(0–50) ratio (p < 0.05). There was a positive correlation between R (−)-flurbiprofen concentration and S (+)-flurbiprofen concentration in plasma (r = 0.725, p < 0.001) as well as in CSF (r = 0.718, p < 0.001), and a negative correlation between plasma and CSF concentration of S (+)-flurbiprofen (r = −0.250, p = 0.037), but not R (−)-flurbiprofen. Conclusion: Distribution of R (−)- and S (+)-flurbiprofen in plasma and CSF differed significantly. Penetration of R (−)-flurbiprofen into the CNS was lower than S (+)-flurbiprofen.
format Online
Article
Text
id pubmed-8120306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81203062021-05-15 The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects Yao, Han Luo, Xingxian Zhang, Hong An, Haiyan Feng, Wanyu Feng, Yi Front Pharmacol Pharmacology Background: Flurbiprofen axetil is a prodrug that releases the active substance through enzymatic removal of the ester moiety. It is formulated through encapsulation in a lipid microsphere carrier, and widely used to treat perioperative pain. Here, we studied the distribution of R (−)- and S (+)-flurbiprofen in human plasma and cerebrospinal fluid (CSF) after intravenous injection of flurbiprofen axetil. Methods: A total of 70 adult patients undergoing elective lower limb surgery under spinal anesthesia were given a single intravenous injection of 100-mg flurbiprofen axetil. The patients were randomly assigned to 10 groups for plasma and CSF sampling at 10 time points (5–50 min) after subarachnoid puncture and before actual spinal anesthesia. R (−)- and S (+)-flurbiprofen and CSF/plasma ratio were determined by liquid chromatography–tandem mass spectrometry. Results: R (−)-flurbiprofen concentration ranged from 2.01 to 10.9 μg/mL in plasma and 1.46–34.4 ng/mL in CSF. S (+)-flurbiprofen concentration ranged from 1.18 to 10.8 μg/mL in plasma and from 2.53 to 47 ng/mL in CSF. In comparison to S (+)-flurbiprofen, R (−)-flurbiprofen concentration was significantly higher in plasma at all time points (p < 0.05) except at 30 or 40 min, and lower in CSF at all time points (p < 0.05) except at 10, 15 and 40 min. Analysis after correcting drug concentration for body mass index also revealed higher plasma and lower CSF R (−)-flurbiprofen concentration. In comparison to S (+)-flurbiprofen, AUC(0–50) for R (−)-flurbiprofen was larger in plasma and smaller in CSF (p < 0.05 for both), and accordingly smaller CSF/plasma AUC(0–50) ratio (p < 0.05). There was a positive correlation between R (−)-flurbiprofen concentration and S (+)-flurbiprofen concentration in plasma (r = 0.725, p < 0.001) as well as in CSF (r = 0.718, p < 0.001), and a negative correlation between plasma and CSF concentration of S (+)-flurbiprofen (r = −0.250, p = 0.037), but not R (−)-flurbiprofen. Conclusion: Distribution of R (−)- and S (+)-flurbiprofen in plasma and CSF differed significantly. Penetration of R (−)-flurbiprofen into the CNS was lower than S (+)-flurbiprofen. Frontiers Media S.A. 2021-04-30 /pmc/articles/PMC8120306/ /pubmed/33995057 http://dx.doi.org/10.3389/fphar.2021.646196 Text en Copyright © 2021 Yao, Luo, Zhang, An, Feng and Feng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yao, Han
Luo, Xingxian
Zhang, Hong
An, Haiyan
Feng, Wanyu
Feng, Yi
The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
title The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
title_full The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
title_fullStr The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
title_full_unstemmed The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
title_short The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
title_sort comparison of plasma and cerebrospinal fluid r(−)- and s(+)-flurbiprofen concentration after intravenous injection of flurbiprofen axetil in human subjects
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120306/
https://www.ncbi.nlm.nih.gov/pubmed/33995057
http://dx.doi.org/10.3389/fphar.2021.646196
work_keys_str_mv AT yaohan thecomparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT luoxingxian thecomparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT zhanghong thecomparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT anhaiyan thecomparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT fengwanyu thecomparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT fengyi thecomparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT yaohan comparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT luoxingxian comparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT zhanghong comparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT anhaiyan comparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT fengwanyu comparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects
AT fengyi comparisonofplasmaandcerebrospinalfluidrandsflurbiprofenconcentrationafterintravenousinjectionofflurbiprofenaxetilinhumansubjects